High Uptake of 123I-metaiodobenzylguanidine Related to Olfactory Neuroblastoma Revealed by Single-photon Emission CT

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2000 Apr 27

PMID 10782784

Citations 2

Authors

T Sasajima

H Kinouchi

N Tomura

J Watarai

K Mizoi

Affiliations

Soon will be listed here.

Abstract

We studied a case of olfactory neuroblastoma by noting 123I-metaiodobenzylguanidine (MIBG) uptake revealed by single-photon emission CT (SPECT). MR imaging revealed an enhancing tumor extending from the left nasal cavity to the bilateral anterior frontal cranial fossae. SPECT revealed high 123I-MIBG uptake in the enhancing tumor. SPECT-revealed 123I-MIBG uptake appears to be clinically useful for distinguishing olfactory neuroblastomas from other tumors, especially suprasellar meningiomas.

Citing Articles

123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study.

Sasajima T, Kinouchi H, Naitoh Y, Tomura N, Watarai J, Mizoi K J Neurooncol. 2005; 77(2):185-91.

PMID: 16314956 DOI: 10.1007/s11060-005-9021-0.

Medulloblastoma with extensive nodularity: single photon emission CT study with iodine-123 metaiodobenzylguanidine.

Naitoh Y, Sasajima T, Kinouchi H, Mikawa S, Mizoi K AJNR Am J Neuroradiol. 2002; 23(9):1564-7.

PMID: 12372749 PMC: 7976800.

References

Ramsay H, Kairemo K, Jekunen A . Somatostatin receptor imaging of olfactory neuroblastoma. J Laryngol Otol. 1996; 110(12):1161-3. DOI: 10.1017/s0022215100136023. View

Troncone L, Rufini V, Montemaggi P, Danza F, Lasorella A, Mastrangelo R . The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience. Eur J Nucl Med. 1990; 16(4-6):325-35. DOI: 10.1007/BF00842788. View

Leung A, Shapiro B, HATTNER R, Kim E, de Kraker J, Ghazzar N . Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med. 1997; 38(9):1352-7. View

Lamszus K, Meyerhof W, Westphal M . Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas. J Neurooncol. 1998; 35(3):353-64. DOI: 10.1023/a:1005893223090. View

Polin R, Sheehan J, Chenelle A, Munoz E, Larner J, Phillips C . The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery. 1998; 42(5):1029-37. DOI: 10.1097/00006123-199805000-00045. View

Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D . Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res. 1985; 45(12 Pt 1):6366-70. View

Sisson J, Wieland D, Sherman P, Mangner T, Tobes M, Jacques Jr S . Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med. 1987; 28(10):1620-4. View

Paltiel H, Gelfand M, Elgazzar A, Washburn L, Harris R, Masters P . Neural crest tumors: I-123 MIBG imaging in children. Radiology. 1994; 190(1):117-21. DOI: 10.1148/radiology.190.1.8259387. View

Derdeyn C, Moran C, Wippold 2nd F, Chason D, Koby M, Rodriguez F . MRI of esthesioneuroblastoma. J Comput Assist Tomogr. 1994; 18(1):16-21. DOI: 10.1097/00004728-199401000-00004. View

10.

Gaze M, Huxham I, Mairs R, Barrett A . Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging. Int J Cancer. 1991; 47(6):875-80. DOI: 10.1002/ijc.2910470615. View

11.

Hoefnagel C . Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med. 1994; 21(6):561-81. DOI: 10.1007/BF00173045. View

12.

Bomanji J, Moyes J, Huneidi A, Solanki K, Hawkins L, Nimmon C . Cerebral uptake of MIBG: adrenoceptors visualized?. Nucl Med Commun. 1991; 12(1):3-13. DOI: 10.1097/00006231-199101000-00002. View

13.

Smets L, Loesberg C, Janssen M, Metwally E, Huiskamp R . Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res. 1989; 49(11):2941-4. View

14.

Goldsweig H, Sundaresan N . Chemotherapy of recurrent esthesioneuroblastoma. Case report and review of the literature. Am J Clin Oncol. 1990; 13(2):139-43. DOI: 10.1097/00000421-199004000-00010. View

15.

Dwamena B, Zempel S, Klopper J, Van Heerden B, Wieland D, Shapiro B . Brain uptake of iodine-131 metaiodobenzylguanidine following therapy of malignant pheochromocytoma. Clin Nucl Med. 1998; 23(7):441-5. DOI: 10.1097/00003072-199807000-00009. View

16.

Nakajo M, Shapiro B, Copp J, Kalff V, Gross M, Sisson J . The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med. 1983; 24(8):672-82. View

17.

Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Leclere J . Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res. 1988; 271:689-705. View

18.

Wafelman A, Hoefnagel C, Maes R, Beijnen J . Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med. 1994; 21(6):545-59. DOI: 10.1007/BF00173043. View

19.

Rufini V, Giordano A, Di Giuda D, Petrone A, Deb G, De Sio L . [123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med. 1995; 39(4 Suppl 1):25-8. View